CMC & ManufacturingLast reviewed April 2026

Stability Testing(Stability)

Testing to determine how a drug product's quality changes over time under the influence of environmental factors.

Usage Examples

Long-term stability data supports a 36-month shelf life.
Accelerated stability results showed no significant degradation.
The stability protocol includes 12 timepoints over 24 months.

What is Stability?

Stability testing evaluates how the quality of a drug substance or drug product varies with time under the influence of temperature, humidity, and light. Stability data supports shelf life determination, storage conditions, and demonstrates the product remains within specifications throughout its intended use period.

ICH Q1A defines stability testing conditions and duration for different climatic zones. Studies include long-term (25°C/60%RH), intermediate (30°C/65%RH), and accelerated (40°C/75%RH) conditions. Photostability testing per ICH Q1B evaluates light sensitivity.

Stability protocols specify test conditions, timepoints, attributes to test, and acceptance criteria. Data supports expiration dating and may be used to justify shipping conditions or temporary excursions.

Regulatory Context

This term appears most often in cmc & manufacturing workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside ICH Q1A, ICH Q1B, ICH Q1C.

FDAICHHealth Canada

When This Matters

Long-term stability data supports a 36-month shelf life.
Accelerated stability results showed no significant degradation.
The stability protocol includes 12 timepoints over 24 months.

Common Mistakes

Failing to align CMC change narratives with current CFR/ICH expectations.
Submitting incomplete control strategy documentation.
Separating manufacturing and regulatory review cycles too late in execution.

Related Regulations

ICH Q1AICH Q1BICH Q1CICH Q1DICH Q1E

How to Design an ICH Q1A Stability Study

Design and execute a stability study compliant with ICH Q1A(R2) to support drug substance or drug product shelf-life determination.

1
Define study objectives
Determine whether the study supports: initial shelf-life determination (registration), shelf-life extension, post-approval stability commitment, or investigational stability. Objective drives design depth.
2
Identify representative batches
Per ICH Q1A(R2): three primary batches of drug substance (two pilot scale, one laboratory acceptable for NCE) or three primary batches of drug product (two pilot scale minimum). Batches must represent the intended commercial manufacturing process.
3
Select storage conditions
Long-term: 25°C/60% RH for most drugs (intermediate 30°C/65% RH and accelerated 40°C/75% RH). Zone IV climatic zones use different conditions. Refrigerated and frozen products have their own protocols. Photostability per Q1B separately.
4
Define testing frequency
Long-term: 0, 3, 6, 9, 12, 18, 24 months and annually thereafter. Accelerated: 0, 3, 6 months. Intermediate (when needed): 0, 6, 12 months. Protocol stops at proposed shelf life plus sufficient data for extension.
5
Select stability-indicating test methods
Identity, assay, impurity profile (related substances), degradation products, physical attributes relevant to the dosage form. Methods must be stability-indicating — validated to detect degradation products over time.
6
Execute the protocol
Store samples per protocol, pull at specified timepoints, test using validated methods, record results in the stability database. Maintain chain-of-custody and temperature monitoring of storage chambers.
7
Analyze and evaluate data
Per ICH Q1E: trend analysis of each CQA over time. Determine whether data support the proposed shelf life with appropriate statistical evaluation (regression analysis where applicable). Evaluate batch-to-batch variability.
8
File in Module 3.2.P.8
Submit stability data in Module 3.2.P.8 of the eCTD with: stability summary and conclusions (3.2.P.8.1), post-approval stability commitment (3.2.P.8.2), and stability data tables and graphs (3.2.P.8.3). Support proposed shelf life and storage conditions.

Frequently Asked Questions

ICH Q1A requires long-term (25°C/60%RH for Zone I/II), intermediate (30°C/65%RH), and accelerated (40°C/75%RH) testing. Additional conditions apply for Zone III/IV countries, refrigerated products, or frozen products.

Typically 6 months accelerated and 12+ months long-term data at submission. Shelf life approved depends on available data, with extrapolation possible per ICH Q1E based on understanding of degradation pathways.

An analytical method that accurately measures the active ingredient and its degradation products, distinguishing them from excipients and impurities. Required to demonstrate method can detect stability changes.